According to Latest Research, the global market for Vascular Disrupting Agents should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

China Vascular Disrupting Agents market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

The United States Vascular Disrupting Agents market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

In terms of type, Oral segment holds a share about % in 2023 and will reach % in 2030; while in terms of application, Hospital has a share approximately % in 2023 and will grow at a CAGR % during 2023 and 2030.

The global key manufacturers of Vascular Disrupting Agents include AGC Biologics, Avid Bioservices, Bionomics, Beijing Shenogen Biomedical, Mateon Therapeutics, Myrexis, VBL Therapeutics, Steba biotech and BeyondSpring Pharmaceutical, etc. In 2023, the global top five players hold a share approximately % in terms of revenue.

This report aims to provide a comprehensive study of the global market for Vascular Disrupting Agents. Report Highlights:

(1) Global Vascular Disrupting Agents market size (sales volume & revenue), history data from 2019-2023 and forecast data from 2023 to 2030.

(2) Global Vascular Disrupting Agents market competitive situation, sales, revenue, price and market share, from 2019 to 2023.

(3) China Vascular Disrupting Agents market competitive situation, sales, revenue, price and market share, from 2019 to 2023.

(4) Global Vascular Disrupting Agents segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.

(5) Global Vascular Disrupting Agents segment by type and by application and regional segment by type and by application.

(6) Global major production regions of Vascular Disrupting Agents, capacity, production and trends.

(7) Vascular Disrupting Agents industry supply chain, upstream, midstream and downstream analysis.

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa

Market segment by type, covers

Oral

Vein

Market segment by application, can be divided into

Hospital

Specialty Clinic

Others

Market segment by players, this report covers

AGC Biologics

Avid Bioservices

Bionomics

Beijing Shenogen Biomedical

Mateon Therapeutics

Myrexis

VBL Therapeutics

Steba biotech

BeyondSpring Pharmaceutical

Immune Pharmaceuticals

Nereus Pharmaceuticals

Madrigal Pharmaceuticals

Celgene Corporation

Bionomics

Lees Pharmaceutical Holdings

1 Market Overview

1.1 Vascular Disrupting Agents Definition

1.2 Global Vascular Disrupting Agents Market Size and Forecast

1.2.1 By Revenue, Global Vascular Disrupting Agents Market Size, 2019-2030

1.2.2 By Sales Volume, Global Vascular Disrupting Agents Market Size, 2019-2030

1.2.3 Global Vascular Disrupting Agents Price Trend, 2019-2030

1.3 China Vascular Disrupting Agents Market Size and Forecast

1.3.1 By Revenue, China Vascular Disrupting Agents Market Size, 2019-2030

1.3.2 By Sales Volume, China Vascular Disrupting Agents Market Size, 2019-2030

1.3.3 China Vascular Disrupting Agents Price Trend, 2019-2030

1.4 China Percentage in Global Market

1.4.1 By Revenue, China Vascular Disrupting Agents Share in Global Market, 2019-2030

1.4.2 By Sales Volume, China Vascular Disrupting Agents Share in Global Market, 2019-2030

1.4.3 Vascular Disrupting Agents Market Size: China VS Global, 2019-2030

1.5 Vascular Disrupting Agents Market Dynamics

1.5.1 Vascular Disrupting Agents Market Drivers

1.5.2 Vascular Disrupting Agents Market Restraints

1.5.3 Vascular Disrupting Agents Industry Trends

1.5.4 Vascular Disrupting Agents Industry Policy

2 Global Competitive Landscape by Company

2.1 Global Vascular Disrupting Agents Revenue by Company, 2019-2023

2.2 Global Vascular Disrupting Agents Sales Volume by Company, 2019-2023

2.3 Global Vascular Disrupting Agents Price by Company, 2019-2023

2.4 Global Vascular Disrupting Agents Participants, Market Position (Tier 1, Tier 2 and Tier 3)

2.5 Global Vascular Disrupting Agents Concentration Ratio

2.6 Global Vascular Disrupting Agents Mergers & Acquisitions, Expansion Plans

2.7 Global Vascular Disrupting Agents Manufacturers Product Type

3 China Competitive Landscape by Company

3.1 China Vascular Disrupting Agents Revenue by Company, 2019-2023

3.2 China Vascular Disrupting Agents Sales Volume by Company, 2019-2023

3.3 China Vascular Disrupting Agents Vascular Disrupting Agents Participants, Market Position (Tier 1, Tier 2 and Tier 3)

3.4 China Vascular Disrupting Agents Market, Sales Percentage of Local Players VS Foreign Players (2019-2023)

3.5 Chinese Local Players, Vascular Disrupting Agents Domestic VS Export

3.6 China Market, Vascular Disrupting Agents Import & Export

3.6.1 China Market, Vascular Disrupting Agents Import & Export, 2019-2030

3.6.2 China Vascular Disrupting Agents Import & Export Trends

3.6.3 Main Sources of China Vascular Disrupting Agents Import

3.6.4 Export Destination of China Vascular Disrupting Agents

4 Vascular Disrupting Agents Production by Region

4.1 Global Vascular Disrupting Agents Capacity, Production and Capacity Utilization, 2019-2030

4.2 Global Geographic Distribution of Vascular Disrupting Agents Manufacturers

4.3 Global Major Manufacturers, Vascular Disrupting Agents Capacity Expansion and Future Plans

4.4 Global Vascular Disrupting Agents Capacity by Region

4.5 Global Vascular Disrupting Agents Production by Region

4.5.1 Global Vascular Disrupting Agents Production & Forecast by Region, 2019 VS 2023 VS 2030

4.5.2 Global Vascular Disrupting Agents Production by Region, 2019-2023

4.5.3 Global Vascular Disrupting Agents Production Market Share & Forecast by Region, 2019-2030

5 Industry Chain Analysis

5.1 Vascular Disrupting Agents Industry Chain

5.2 Vascular Disrupting Agents Upstream Analysis

5.2.1 Vascular Disrupting Agents Core Raw Materials

5.2.2 Main Manufacturers of Vascular Disrupting Agents Core Raw Materials

5.3 Midstream Analysis

5.4 Downstream Analysis

5.5 Vascular Disrupting Agents Production Mode

5.6 Vascular Disrupting Agents Procurement Model

5.7 Vascular Disrupting Agents Industry Sales Model and Sales Channels

5.7.1 Vascular Disrupting Agents Sales Model

5.7.2 Vascular Disrupting Agents Typical Distributors

6 Sights by Type

6.1 Vascular Disrupting Agents Classification

6.1.1 Oral

6.1.2 Vein

6.2 By Type, Global Vascular Disrupting Agents Market Size & CAGR, 2019 VS 2023 VS 2030

6.3 By Type, Global Vascular Disrupting Agents Revenue, 2019-2030

6.4 By Type, Global Vascular Disrupting Agents Sales Volume, 2019-2030

6.5 By Type, Global Vascular Disrupting Agents Price, 2019-2030

7 Sights by Application

7.1 Vascular Disrupting Agents Segment by Application

7.1.1 Hospital

7.1.2 Specialty Clinic

7.1.3 Others

7.2 By Application, Global Vascular Disrupting Agents Market Size & CAGR, 2019 VS 2023 VS 2030

7.3 By Application, Global Vascular Disrupting Agents Revenue, 2019-2030

7.4 By Application, Global Vascular Disrupting Agents Sales Volume, 2019-2030

7.5 By Application, Global Vascular Disrupting Agents Price, 2019-2030

8 Sales Sights by Region

8.1 By Region, Global Vascular Disrupting Agents Market Size, 2019 VS 2023 VS 2030

8.2 By Region, Global Vascular Disrupting Agents Revenue, 2019-2030

8.3 By Region, Global Vascular Disrupting Agents Sales Volume, 2019-2030

8.4 North America

8.4.1 North America Vascular Disrupting Agents Market Size & Forecasts, 2019-2030

8.4.2 By Country, North America Vascular Disrupting Agents Market Size Market Share

8.5 Europe

8.5.1 Europe Vascular Disrupting Agents Market Size & Forecasts, 2019-2030

8.5.2 By Country, Europe Vascular Disrupting Agents Market Size Market Share

8.6 Asia Pacific

8.6.1 Asia Pacific Vascular Disrupting Agents Market Size & Forecasts, 2019-2030

8.6.2 By Country/Region, Asia Pacific Vascular Disrupting Agents Market Size Market Share

8.7 South America

8.7.1 South America Vascular Disrupting Agents Market Size & Forecasts, 2019-2030

8.7.2 By Country, South America Vascular Disrupting Agents Market Size Market Share

8.8 Middle East & Africa

9 Sales Sights by Country Level

9.1 By Country, Global Vascular Disrupting Agents Market Size & CAGR，2019 VS 2023 VS 2030

9.2 By Country, Global Vascular Disrupting Agents Revenue, 2019-2030

9.3 By Country, Global Vascular Disrupting Agents Sales Volume, 2019-2030

9.4 U.S.

9.4.1 U.S. Vascular Disrupting Agents Market Size, 2019-2030

9.4.2 By Company, U.S. Vascular Disrupting Agents Sales Volume Market Share, 2023

9.4.3 By Type, U.S. Vascular Disrupting Agents Market Size, Share, 2023 VS 2030

9.4.4 By Application, U.S. Vascular Disrupting Agents Market Size, Share, 2023 VS 2030

9.5 Europe

9.5.1 Europe Vascular Disrupting Agents Market Size, 2019-2030

9.5.2 By Company, Europe Vascular Disrupting Agents Sales Volume Market Share, 2023

9.5.3 By Type, Europe Vascular Disrupting Agents Market Size, Share, 2023 VS 2030

9.5.4 By Application, Europe Vascular Disrupting Agents Market Size, Share, 2023 VS 2030

9.6 China

9.6.1 China Vascular Disrupting Agents Market Size, 2019-2030

9.6.2 By Company, China Vascular Disrupting Agents Sales Volume Market Share, 2023

9.6.3 By Type, China Vascular Disrupting Agents Market Size, Share, 2023 VS 2030

9.6.4 By Application, China Vascular Disrupting Agents Market Size, Share, 2023 VS 2030

9.7 Japan

9.7.1 Japan Vascular Disrupting Agents Market Size, 2019-2030

9.7.2 By Company, Japan Vascular Disrupting Agents Sales Volume Market Share, 2023

9.7.3 By Type, Japan Vascular Disrupting Agents Market Size, Share, 2023 VS 2030

9.7.4 By Application, Japan Vascular Disrupting Agents Market Size, Share, 2023 VS 2030

9.8 South Korea

9.8.1 South Korea Vascular Disrupting Agents Market Size, 2019-2030

9.8.2 By Company, South Korea Vascular Disrupting Agents Sales Volume Market Share, 2023

9.8.3 By Type, South Korea Vascular Disrupting Agents Market Size, Share, 2023 VS 2030

9.8.4 By Application, South Korea Vascular Disrupting Agents Market Size, Share, 2023 VS 2030

9.9 Southeast Asia

9.9.1 Southeast Asia Vascular Disrupting Agents Market Size, 2019-2030

9.9.2 By Company, Southeast Asia Vascular Disrupting Agents Sales Volume Market Share, 2023

9.9.3 By Type, Southeast Asia Vascular Disrupting Agents Market Size, Share, 2023 VS 2030

9.9.4 By Application, Southeast Asia Vascular Disrupting Agents Market Size, Share, 2023 VS 2030

9.10 India

9.10.1 India Vascular Disrupting Agents Market Size, 2019-2030

9.10.2 By Company, India Vascular Disrupting Agents Sales Volume Market Share, 2023

9.10.3 By Type, India Vascular Disrupting Agents Market Size, Share, 2023 VS 2030

9.10.4 By Application, India Vascular Disrupting Agents Market Size, Share, 2023 VS 2030

9.11 Middle East & Asia

9.11.1 Middle East & Asia Vascular Disrupting Agents Market Size, 2019-2030

9.11.2 By Company, Middle East & Asia Vascular Disrupting Agents Sales Volume Market Share, 2023

9.11.3 By Type, Middle East & Asia Vascular Disrupting Agents Market Size, Share, 2023 VS 2030

9.11.4 By Application, Middle East & Asia Vascular Disrupting Agents Market Size, Share, 2023 VS 2030

10 Manufacturers Profile

10.1 AGC Biologics

10.1.1 AGC Biologics Company Information, Head Office, Market Area and Industry Position

10.1.2 AGC Biologics Vascular Disrupting Agents Models, Specifications and Application

10.1.3 AGC Biologics Vascular Disrupting Agents Sales Volume, Revenue, Price and Gross Margin, 2019-2023

10.1.4 AGC Biologics Company Profile and Main Business

10.1.5 AGC Biologics Recent Developments

10.2 Avid Bioservices

10.2.1 Avid Bioservices Company Information, Head Office, Market Area and Industry Position

10.2.2 Avid Bioservices Vascular Disrupting Agents Models, Specifications and Application

10.2.3 Avid Bioservices Vascular Disrupting Agents Sales Volume, Revenue, Price and Gross Margin, 2019-2023

10.2.4 Avid Bioservices Company Profile and Main Business

10.2.5 Avid Bioservices Recent Developments

10.3 Bionomics

10.3.1 Bionomics Company Information, Head Office, Market Area and Industry Position

10.3.2 Bionomics Vascular Disrupting Agents Models, Specifications and Application

10.3.3 Bionomics Vascular Disrupting Agents Sales Volume, Revenue, Price and Gross Margin, 2019-2023

10.3.4 Bionomics Company Profile and Main Business

10.3.5 Bionomics Recent Developments

10.4 Beijing Shenogen Biomedical

10.4.1 Beijing Shenogen Biomedical Company Information, Head Office, Market Area and Industry Position

10.4.2 Beijing Shenogen Biomedical Vascular Disrupting Agents Models, Specifications and Application

10.4.3 Beijing Shenogen Biomedical Vascular Disrupting Agents Sales Volume, Revenue, Price and Gross Margin, 2019-2023

10.4.4 Beijing Shenogen Biomedical Company Profile and Main Business

10.4.5 Beijing Shenogen Biomedical Recent Developments

10.5 Mateon Therapeutics

10.5.1 Mateon Therapeutics Company Information, Head Office, Market Area and Industry Position

10.5.2 Mateon Therapeutics Vascular Disrupting Agents Models, Specifications and Application

10.5.3 Mateon Therapeutics Vascular Disrupting Agents Sales Volume, Revenue, Price and Gross Margin, 2019-2023

10.5.4 Mateon Therapeutics Company Profile and Main Business

10.5.5 Mateon Therapeutics Recent Developments

10.6 Myrexis

10.6.1 Myrexis Company Information, Head Office, Market Area and Industry Position

10.6.2 Myrexis Vascular Disrupting Agents Models, Specifications and Application

10.6.3 Myrexis Vascular Disrupting Agents Sales Volume, Revenue, Price and Gross Margin, 2019-2023

10.6.4 Myrexis Company Profile and Main Business

10.6.5 Myrexis Recent Developments

10.7 VBL Therapeutics

10.7.1 VBL Therapeutics Company Information, Head Office, Market Area and Industry Position

10.7.2 VBL Therapeutics Vascular Disrupting Agents Models, Specifications and Application

10.7.3 VBL Therapeutics Vascular Disrupting Agents Sales Volume, Revenue, Price and Gross Margin, 2019-2023

10.7.4 VBL Therapeutics Company Profile and Main Business

10.7.5 VBL Therapeutics Recent Developments

10.8 Steba biotech

10.8.1 Steba biotech Company Information, Head Office, Market Area and Industry Position

10.8.2 Steba biotech Vascular Disrupting Agents Models, Specifications and Application

10.8.3 Steba biotech Vascular Disrupting Agents Sales Volume, Revenue, Price and Gross Margin, 2019-2023

10.8.4 Steba biotech Company Profile and Main Business

10.8.5 Steba biotech Recent Developments

10.9 BeyondSpring Pharmaceutical

10.9.1 BeyondSpring Pharmaceutical Company Information, Head Office, Market Area and Industry Position

10.9.2 BeyondSpring Pharmaceutical Vascular Disrupting Agents Models, Specifications and Application

10.9.3 BeyondSpring Pharmaceutical Vascular Disrupting Agents Sales Volume, Revenue, Price and Gross Margin, 2019-2023

10.9.4 BeyondSpring Pharmaceutical Company Profile and Main Business

10.9.5 BeyondSpring Pharmaceutical Recent Developments

10.10 Immune Pharmaceuticals

10.10.1 Immune Pharmaceuticals Company Information, Head Office, Market Area and Industry Position

10.10.2 Immune Pharmaceuticals Vascular Disrupting Agents Models, Specifications and Application

10.10.3 Immune Pharmaceuticals Vascular Disrupting Agents Sales Volume, Revenue, Price and Gross Margin, 2019-2023

10.10.4 Immune Pharmaceuticals Company Profile and Main Business

10.10.5 Immune Pharmaceuticals Recent Developments

10.11 Nereus Pharmaceuticals

10.11.1 Nereus Pharmaceuticals Company Information, Head Office, Market Area and Industry Position

10.11.2 Nereus Pharmaceuticals Vascular Disrupting Agents Models, Specifications and Application

10.11.3 Nereus Pharmaceuticals Vascular Disrupting Agents Sales Volume, Revenue, Price and Gross Margin, 2019-2023

10.11.4 Nereus Pharmaceuticals Company Profile and Main Business

10.11.5 Nereus Pharmaceuticals Recent Developments

10.12 Madrigal Pharmaceuticals

10.12.1 Madrigal Pharmaceuticals Company Information, Head Office, Market Area and Industry Position

10.12.2 Madrigal Pharmaceuticals Vascular Disrupting Agents Models, Specifications and Application

10.12.3 Madrigal Pharmaceuticals Vascular Disrupting Agents Sales Volume, Revenue, Price and Gross Margin, 2019-2023

10.12.4 Madrigal Pharmaceuticals Company Profile and Main Business

10.12.5 Madrigal Pharmaceuticals Recent Developments

10.13 Celgene Corporation

10.13.1 Celgene Corporation Company Information, Head Office, Market Area and Industry Position

10.13.2 Celgene Corporation Vascular Disrupting Agents Models, Specifications and Application

10.13.3 Celgene Corporation Vascular Disrupting Agents Sales Volume, Revenue, Price and Gross Margin, 2019-2023

10.13.4 Celgene Corporation Company Profile and Main Business

10.13.5 Celgene Corporation Recent Developments

10.14 Bionomics

10.14.1 Bionomics Company Information, Head Office, Market Area and Industry Position

10.14.2 Bionomics Vascular Disrupting Agents Models, Specifications and Application

10.14.3 Bionomics Vascular Disrupting Agents Sales Volume, Revenue, Price and Gross Margin, 2019-2023

10.14.4 Bionomics Company Profile and Main Business

10.14.5 Bionomics Recent Developments

10.15 Lees Pharmaceutical Holdings

10.15.1 Lees Pharmaceutical Holdings Company Information, Head Office, Market Area and Industry Position

10.15.2 Lees Pharmaceutical Holdings Vascular Disrupting Agents Models, Specifications and Application

10.15.3 Lees Pharmaceutical Holdings Vascular Disrupting Agents Sales Volume, Revenue, Price and Gross Margin, 2019-2023

10.15.4 Lees Pharmaceutical Holdings Company Profile and Main Business

10.15.5 Lees Pharmaceutical Holdings Recent Developments

11 Conclusion

12 Appendix

12.1 Research Methodology

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Market Estimation Model

12.4 Disclaimer

Table 1. Vascular Disrupting Agents Market Size & CAGR: China VS Global, 2019-2030, US$ Million

Table 2. Vascular Disrupting Agents Market Restraints

Table 3. Vascular Disrupting Agents Market Trends

Table 4. Vascular Disrupting Agents Industry Policy

Table 5. Global Vascular Disrupting Agents Revenue by Company, 2019-2023, US$ million

Table 6. Global Vascular Disrupting Agents Revenue Market Share by Company, 2019-2023

Table 7. Global Vascular Disrupting Agents Sales Volume by Company, 2019-2023, (K Units)

Table 8. Global Vascular Disrupting Agents Sales Volume Market Share by Company, 2019-2023

Table 9. Global Vascular Disrupting Agents Price by Company, 2019-2023, (US$/Unit)

Table 10. Global Vascular Disrupting Agents Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Vascular Disrupting Agents Mergers & Acquisitions, Expansion Plans

Table 12. Global Vascular Disrupting Agents Manufacturers Product Type

Table 13. China Vascular Disrupting Agents Revenue by Company, 2019-2023, US$ million

Table 14. China Vascular Disrupting Agents Revenue Market Share by Company, 2019-2023

Table 15. China Vascular Disrupting Agents Sales Volume by Company, 2019-2023, (K Units)

Table 16. China Vascular Disrupting Agents Sales Volume Market Share by Company, 2019-2023

Table 17. China Market, Vascular Disrupting Agents Production, Sales, Import and Export, 2019-2030, (K Units)

Table 18. China Vascular Disrupting Agents Import & Export Trends

Table 19. Main Sources of China Vascular Disrupting Agents Import

Table 20. Export Destination of China Vascular Disrupting Agents

Table 21. Global Headquarters and Manufacturing Base of Vascular Disrupting Agents Manufacturers

Table 22. Global Major Manufacturers, Vascular Disrupting Agents Capacity Expansion and Future Plans

Table 23. Global Vascular Disrupting Agents Production & Forecast by Region, 2019 VS 2023 VS 2030, (K Units)

Table 24. Global Vascular Disrupting Agents Production by Region, 2019-2023, (K Units)

Table 25. Global Vascular Disrupting Agents Production Forecast by Region, 2024-2030, (K Units)

Table 26. Global Key Players of Vascular Disrupting Agents Upstream (Raw Materials)

Table 27. Global Vascular Disrupting Agents Typical Customers

Table 28. Vascular Disrupting Agents Typical Distributors

Table 29. By Type, Global Vascular Disrupting Agents Revenue & CAGR, 2019 VS 2023 VS 2030, US$ Million

Table 30. By Application, Global Vascular Disrupting Agents Revenue & CAGR, 2019 VS 2023 VS 2030, US$ Million

Table 31. By Region, Global Vascular Disrupting Agents Market Size, 2019 VS 2023 VS 2030, US$ Million

Table 32. By Region, Global Vascular Disrupting Agents Revenue, 2019-2030, US$ Million

Table 33. By Region, Global Vascular Disrupting Agents Sales Volume, 2019-2030, (K Units)

Table 34. By Country, Global Vascular Disrupting Agents Revenue & CAGR，2019 VS 2023 VS 2030, US$ Million

Table 35. By Country, Global Vascular Disrupting Agents Revenue, 2019-2030, US$ Million

Table 36. By Country, Global Vascular Disrupting Agents Revenue Market Share, 2019-2030

Table 37. By Country, Global Vascular Disrupting Agents Sales Volume, 2019-2030, (K Units)

Table 38. By Country, Global Vascular Disrupting Agents Sales Volume Market Share, 2019-2030

Table 39. AGC Biologics Company Information, Head Office, Market Area and Industry Position

Table 40. AGC Biologics Vascular Disrupting Agents Models, Specifications and Application

Table 41. AGC Biologics Vascular Disrupting Agents Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 42. AGC Biologics Company Profile and Main Business

Table 43. AGC Biologics Recent Developments

Table 44. Avid Bioservices Company Information, Head Office, Market Area and Industry Position

Table 45. Avid Bioservices Vascular Disrupting Agents Models, Specifications and Application

Table 46. Avid Bioservices Vascular Disrupting Agents Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 47. Avid Bioservices Company Profile and Main Business

Table 48. Avid Bioservices Recent Developments

Table 49. Bionomics Company Information, Head Office, Market Area and Industry Position

Table 50. Bionomics Vascular Disrupting Agents Models, Specifications and Application

Table 51. Bionomics Vascular Disrupting Agents Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 52. Bionomics Company Profile and Main Business

Table 53. Bionomics Recent Developments

Table 54. Beijing Shenogen Biomedical Company Information, Head Office, Market Area and Industry Position

Table 55. Beijing Shenogen Biomedical Vascular Disrupting Agents Models, Specifications and Application

Table 56. Beijing Shenogen Biomedical Vascular Disrupting Agents Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 57. Beijing Shenogen Biomedical Company Profile and Main Business

Table 58. Beijing Shenogen Biomedical Recent Developments

Table 59. Mateon Therapeutics Company Information, Head Office, Market Area and Industry Position

Table 60. Mateon Therapeutics Vascular Disrupting Agents Models, Specifications and Application

Table 61. Mateon Therapeutics Vascular Disrupting Agents Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 62. Mateon Therapeutics Company Profile and Main Business

Table 63. Mateon Therapeutics Recent Developments

Table 64. Myrexis Company Information, Head Office, Market Area and Industry Position

Table 65. Myrexis Vascular Disrupting Agents Models, Specifications and Application

Table 66. Myrexis Vascular Disrupting Agents Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 67. Myrexis Company Profile and Main Business

Table 68. Myrexis Recent Developments

Table 69. VBL Therapeutics Company Information, Head Office, Market Area and Industry Position

Table 70. VBL Therapeutics Vascular Disrupting Agents Models, Specifications and Application

Table 71. VBL Therapeutics Vascular Disrupting Agents Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 72. VBL Therapeutics Company Profile and Main Business

Table 73. VBL Therapeutics Recent Developments

Table 74. Steba biotech Company Information, Head Office, Market Area and Industry Position

Table 75. Steba biotech Vascular Disrupting Agents Models, Specifications and Application

Table 76. Steba biotech Vascular Disrupting Agents Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 77. Steba biotech Company Profile and Main Business

Table 78. Steba biotech Recent Developments

Table 79. BeyondSpring Pharmaceutical Company Information, Head Office, Market Area and Industry Position

Table 80. BeyondSpring Pharmaceutical Vascular Disrupting Agents Models, Specifications and Application

Table 81. BeyondSpring Pharmaceutical Vascular Disrupting Agents Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 82. BeyondSpring Pharmaceutical Company Profile and Main Business

Table 83. BeyondSpring Pharmaceutical Recent Developments

Table 84. Immune Pharmaceuticals Company Information, Head Office, Market Area and Industry Position

Table 85. Immune Pharmaceuticals Vascular Disrupting Agents Models, Specifications and Application

Table 86. Immune Pharmaceuticals Vascular Disrupting Agents Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 87. Immune Pharmaceuticals Company Profile and Main Business

Table 88. Immune Pharmaceuticals Recent Developments

Table 89. Nereus Pharmaceuticals Company Information, Head Office, Market Area and Industry Position

Table 90. Nereus Pharmaceuticals Vascular Disrupting Agents Models, Specifications and Application

Table 91. Nereus Pharmaceuticals Vascular Disrupting Agents Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 92. Nereus Pharmaceuticals Company Profile and Main Business

Table 93. Nereus Pharmaceuticals Recent Developments

Table 94. Madrigal Pharmaceuticals Company Information, Head Office, Market Area and Industry Position

Table 95. Madrigal Pharmaceuticals Vascular Disrupting Agents Models, Specifications and Application

Table 96. Madrigal Pharmaceuticals Vascular Disrupting Agents Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 97. Madrigal Pharmaceuticals Company Profile and Main Business

Table 98. Madrigal Pharmaceuticals Recent Developments

Table 99. Celgene Corporation Company Information, Head Office, Market Area and Industry Position

Table 100. Celgene Corporation Vascular Disrupting Agents Models, Specifications and Application

Table 101. Celgene Corporation Vascular Disrupting Agents Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 102. Celgene Corporation Company Profile and Main Business

Table 103. Celgene Corporation Recent Developments

Table 104. Bionomics Company Information, Head Office, Market Area and Industry Position

Table 105. Bionomics Vascular Disrupting Agents Models, Specifications and Application

Table 106. Bionomics Vascular Disrupting Agents Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 107. Bionomics Company Profile and Main Business

Table 108. Bionomics Recent Developments

Table 109. Lees Pharmaceutical Holdings Company Information, Head Office, Market Area and Industry Position

Table 110. Lees Pharmaceutical Holdings Vascular Disrupting Agents Models, Specifications and Application

Table 111. Lees Pharmaceutical Holdings Vascular Disrupting Agents Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 112. Lees Pharmaceutical Holdings Company Profile and Main Business

Table 113. Lees Pharmaceutical Holdings Recent Developments

List of Figure

Figure 1. Vascular Disrupting Agents Picture

Figure 2. By Revenue, Global Vascular Disrupting Agents Market Size and Forecast, 2019-2030, US$ Million

Figure 3. By Sales Volume, Global Vascular Disrupting Agents Market Size and Forecast, 2019-2030, (K Units)

Figure 4. Global Vascular Disrupting Agents Price Trend, 2019-2030, (US$/Unit)

Figure 5. By Revenue, China Vascular Disrupting Agents Market Size and Forecast, 2019-2030, US$ million

Figure 6. By Sales Volume, China Vascular Disrupting Agents Market Size and Forecast, 2019-2030, (K Units)

Figure 7. China Vascular Disrupting Agents Price Trend, 2019-2030 (US$/Unit)

Figure 8. By Revenue, China Vascular Disrupting Agents Share of Global Market, 2019-2030

Figure 9. By Sales Volume, China Vascular Disrupting Agents Share of Global Market, 2019-2030

Figure 10. Global Vascular Disrupting Agents Key Participants, Market Share, 2021 VS 2023 VS 2023

Figure 11. Global Vascular Disrupting Agents Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2023

Figure 12. China Vascular Disrupting Agents Key Participants, Market Share, 2021 VS 2023 VS 2023

Figure 13. China Vascular Disrupting Agents Key Participants, Market Share, 2021 VS 2023 VS 2023

Figure 14. China Vascular Disrupting Agents Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2019-2023

Figure 15. Chinese Local Players, Proportion of Vascular Disrupting Agents Domestic VS Export, 2023

Figure 16. Global Vascular Disrupting Agents Capacity, Production and Capacity Utilization, 2019-2030

Figure 17. Global Vascular Disrupting Agents Capacity Market Share by Region, 2023 VS 2030

Figure 18. Global Vascular Disrupting Agents Production Market Share & Forecast by Region, 2019-2030

Figure 19. Vascular Disrupting Agents Industry Chain

Figure 20. Vascular Disrupting Agents Procurement Model

Figure 21. Vascular Disrupting Agents Sales Model

Figure 22. Vascular Disrupting Agents Sales Channels, Direct Sales and Distribution

Figure 23. Oral

Figure 24. Vein

Figure 25. By Type, Global Vascular Disrupting Agents Revenue, 2019-2030, US$ Million

Figure 26. By Type, Global Vascular Disrupting Agents Revenue Market Share, 2019-2030

Figure 27. By Type, Global Vascular Disrupting Agents Sales Volume, 2019-2030, (K Units)

Figure 28. By Type, Global Vascular Disrupting Agents Sales Volume Market Share, 2019-2030

Figure 29. By Type, Global Vascular Disrupting Agents Price, 2019-2030, (US$/Unit)

Figure 30. Hospital

Figure 31. Specialty Clinic

Figure 32. Others

Figure 33. By Application, Global Vascular Disrupting Agents Revenue, 2019-2030, US$ Million

Figure 34. By Application, Global Vascular Disrupting Agents Revenue Market Share, 2019-2030

Figure 35. By Application, Global Vascular Disrupting Agents Sales Volume, 2019-2030, (K Units)

Figure 36. By Application, Global Vascular Disrupting Agents Sales Volume Market Share, 2019-2030

Figure 37. By Application, Global Vascular Disrupting Agents Price, 2019-2030, (US$/Unit)

Figure 38. By Region, Global Vascular Disrupting Agents Revenue Market Share, 2019-2030

Figure 39. By Region, Global Vascular Disrupting Agents Sales Volume Market Share, 2019-2030

Figure 40. North America Vascular Disrupting Agents Revenue & Forecasts, 2019-2030, US$ Million

Figure 41. By Country, North America Vascular Disrupting Agents Revenue Market Share, 2023

Figure 42. Europe Vascular Disrupting Agents Revenue & Forecasts, 2019-2030, US$ Million

Figure 43. By Country, Europe Vascular Disrupting Agents Revenue Market Share, 2023

Figure 44. Asia Pacific Vascular Disrupting Agents Revenue & Forecasts, 2019-2030, US$ Million

Figure 45. By Country/Region, Asia Pacific Vascular Disrupting Agents Revenue Market Share, 2023

Figure 46. South America Vascular Disrupting Agents Revenue & Forecasts, 2019-2030, US$ Million

Figure 47. By Country, South America Vascular Disrupting Agents Revenue Market Share, 2023

Figure 48. Middle East & Africa Vascular Disrupting Agents Revenue & Forecasts, 2019-2030, US$ Million

Figure 49. U.S. Vascular Disrupting Agents Sales Volume, 2019-2030, (K Units)

Figure 50. By Company, U.S. Vascular Disrupting Agents Market Share, 2023

Figure 51. By Type, U.S. Vascular Disrupting Agents Sales Volume Market Share, 2023 VS 2030

Figure 52. By Application, U.S. Vascular Disrupting Agents Sales Volume Market Share, 2023 VS 2030

Figure 53. Europe Vascular Disrupting Agents Sales Volume, 2019-2030, (K Units)

Figure 54. By Company, Europe Vascular Disrupting Agents Market Share, 2023

Figure 55. By Type, Europe Vascular Disrupting Agents Sales Volume Market Share, 2023 VS 2030

Figure 56. By Application, Europe Vascular Disrupting Agents Sales Volume Market Share, 2023 VS 2030

Figure 57. China Vascular Disrupting Agents Sales Volume, 2019-2030, (K Units)

Figure 58. By Company, China Vascular Disrupting Agents Market Share, 2023

Figure 59. By Type, China Vascular Disrupting Agents Sales Volume Market Share, 2023 VS 2030

Figure 60. By Application, China Vascular Disrupting Agents Sales Volume Market Share, 2023 VS 2030

Figure 61. Japan Vascular Disrupting Agents Sales Volume, 2019-2030, (K Units)

Figure 62. By Company, Japan Vascular Disrupting Agents Market Share, 2023

Figure 63. By Type, Japan Vascular Disrupting Agents Sales Volume Market Share, 2023 VS 2030

Figure 64. By Application, Japan Vascular Disrupting Agents Sales Volume Market Share, 2023 VS 2030

Figure 65. South Korea Vascular Disrupting Agents Sales Volume, 2019-2030, (K Units)

Figure 66. By Company, South Korea Vascular Disrupting Agents Market Share, 2023

Figure 67. By Type, South Korea Vascular Disrupting Agents Sales Volume Market Share, 2023 VS 2030

Figure 68. By Application, South Korea Vascular Disrupting Agents Sales Volume Market Share, 2023 VS 2030

Figure 69. Southeast Asia Vascular Disrupting Agents Sales Volume, 2019-2030, (K Units)

Figure 70. By Company, Southeast Asia Vascular Disrupting Agents Market Share, 2023

Figure 71. By Type, Southeast Asia Vascular Disrupting Agents Sales Volume Market Share, 2023 VS 2030

Figure 72. By Application, Southeast Asia Vascular Disrupting Agents Sales Volume Market Share, 2023 VS 2030

Figure 73. India Vascular Disrupting Agents Sales Volume, 2019-2030, (K Units)

Figure 74. By Company, India Vascular Disrupting Agents Market Share, 2023

Figure 75. By Type, India Vascular Disrupting Agents Sales Volume Market Share, 2023 VS 2030

Figure 76. By Application, India Vascular Disrupting Agents Sales Volume Market Share, 2023 VS 2030

Figure 77. Middle East & Asia Vascular Disrupting Agents Sales Volume, 2019-2030, (K Units)

Figure 78. By Company, Middle East & Asia Vascular Disrupting Agents Market Share, 2023

Figure 79. By Type, Middle East & Asia Vascular Disrupting Agents Sales Volume Market Share, 2023 VS 2030

Figure 80. By Application, Middle East & Asia Vascular Disrupting Agents Sales Volume Market Share, 2023 VS 2030

Figure 81. Research Methodology

Figure 82. Breakdown of Primary Interviews

Figure 83. Bottom-up Approaches

Figure 84. Top-down Approaches

Methodology/Research Approach

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Research Programs/Design

Historical Data (2015-2019)	Industry Trends Competitive Landscape By Company Expansion Mergers and Acquisitions Market Segment by Type by Application By Regions/ Geography	Value Status and Outlook Value for Major Players Market Share Growth Rate Present Situation Analysis Value Market Share Growth Rate Present Situation Analysis
Influencing Factors	Market Environment Government Policy Technological Changes Market Risks	Market Drivers Growing Demand of Downstream Reduction in Cost
Market Forecast (2021-2026)	Overall Size by Type by Application By Regions/Geography	Key Data (Value) Market Share Growth Rate CAGR (2021-2026)

Market Size Estimation

Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).

The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.

Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report

The following figure shows an illustrative representation of the overall market size estimation process used for this study.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Data Source

Secondary Sources

Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.

Market Size	Segmental value Geographic Penetration Product Adoption Rate for Different market	Journals, Websites, and Press Releases Annual Reports and SEC Filings Company Websites and Press Releases Public and Paid Databases Market Intellix Data Repository
Market Position of Top Company	Product Financials Geographic value Mix Total Company value Business/Segmental value Mix
Qualitative Analysis	Influence Factors Market Potential Market Risks and Opportunities Industry Trends Geographical Features Government Policies	Company Websites and Press Releases Public and Paid Databases Annual Reports Industry Associations Market Intellix Data Repository

Primary Sources

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.

Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.

Key Executives Interviewed

Key Data Information from Primary Sources

Primary Sources	Parameters	Key Data
Market Segments(by Application, by Type)	Value by Type Status and Forecast Value by Application Value by Regions, Status and Forecast (2021-2026)	Value Market Share by Type Value Growth Rate by Type Value by Application Percentage and Growth Rate by Application Value Growth Rate and Market Share by Regions Market Size Status and Forecast (2021-2026)
Total Market	Overall Size, Status and Forecast	Market Size Status and Forecast (2021-2026)